KAPI Collaborates With MEDAC For Reliable Access To Medicines And Medical Devices
KAPI Collaborates With MEDAC For Reliable Access To Medicines And Medical Devices
Kenya Association of Pharmaceutical Industry (KAPI) in collaboration with Medical Technology Industry Association of Kenya (MEDAK) have convened a workshop to help pharmaceutical players, including professionals and regulators shape best practices for post-approval processes.
The workshop aims to strengthen regulatory frameworks and identify operational gaps that hinder reliable access to medicines, leading to prolonged shortages of critical medicines, and causing stress on the health systems.
In line with the Government’s commitment towards the realization of Universal Health Coverage (UHC), reliance access to safe, effective, and quality medicines and health technologies is a critical priority.
Speaking at a press conference PPB CEO Dr. Fred Siyoi said that the government through the ministry of interior have launched a multiagency led by Deputy President to deal with quakes and unscrupulous medicine dealers to sanitize the pharmaceutical industry.
“The impact of unregulated pharmacies to the patient is that they pose a great risk because these are not qualified. We are working with the ministry of interior to crackdown those illegal pharmacies. We have issued lisences and we are going round the country.The ministry have capacity and technogy to ensure all unlegitimate chemists have been closed”.
This quackes are there to make profit without knowing they are causing danger to the patients because for you to dispense, that patient has been diagnosed and they have a prescription, those quacks don’t know these things, they may give you something instead of you healing, they send you to an early grave. Dr Syioi stated.
KAPI Chairperson Dr. James Mokoro said that engagement for capacity building will help to enlighten members association personnel that deals with registration of products safety and pharmacology.
“We are here to teach our members as experts both local and international. Capacity building is our key agenda to ensure patients remain health treated with quality medicines, treated by prophesionals and have access to quality product. We need to build more capacity that will be able to handle and deal with changing environment. There are many changes, diseases are mutating and resistance coming up”. Dr Mokoro stated
KAPI represents the industry voice and promotes efficiency in the pharmaceutical industry to ensure medical products and healthcare technologies of the highest quality can be readily available for diagnosis, prevention and treatment of diseases.
MEDAC Chairperson Steven Kipkoti said that they are working together with KAPI and other stakeholders to strengthen the regulatory frameworks and the initiatives that are happening within the landscape of Kenya.
“This is an opportunity where we are bringing both our members who are underneath our association for training and collaborating initiatives. We as MEDAC our key role is to bring expertise on what health technology products are in terms of definition and how they play within the value chain. We are collaborating with KAKI to bring standardization within the regulatory space” Kipkoti said.
MEDAC seeks to promote innovation and better patient outcomes and advance the harmonization of the standards and regulatory requirements applicable to medical technology and the medical technology industry.